Our center is based at King’s College Hospital in London. The clinic receives referrals from all over the world, and acts as a tertiary referral centre for patients from the South East. In a typical year we will see about 200 new patients and fill 400 follow-up slots making this one of the busiest MND clinics in the world.
Specialists
Current trials
In preparation
Phase iii
The Lighthouse 2 trial
Investigator initiated trial
The Lighthouse 2 study is a phase 3 clinical trial in which we will investigate the efficacy of the drug Triumeq.
In preparation
Phase iii
MAGNET
Platform trial
MAGNET is an innovative clinical platform trial in which multiple treatments for ALS are investigated simultaneously.
Recruiting
Phase iii
TUDCA-ALS (TUDCA)
Investigator initiated trial
This trial will evaluate the efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment for people with ALS.